Skip to main content
ECCO Membership

Corporate Membership

With a key interest in IBD, the ECCO Corporate Members follow the ECCO Statutes and ethical standards. Representatives of Corporate Members are invited to attend the General Assembly, but do not hold voting rights.

Corporate Members can benefit from a range of ECCO initiatives based on a commitment of at least 2 consecutive years.

Corporate Members have no input on the overall content of ECCO’s scientific and educational activities and materials.

Please contact the ECCO Office for further information on Corporate Membership.

ECCO gratefully acknowledges the support of the following corporate members in 2025:

abbvie, Logo
ALFASIGMA, Logo
AMGEN, Logo
Bristol Myers Squibb, Logo
BÜHLMANN, Logo
CELLTRION, Logo
Dr. Falk, Logo
FERRING PHARMACEUTICALS, Logo
GILEAD, Logo
Johnson & Johnson, Logo
Lilly – A MEDICINE COMPANY, Logo
MSD, Logo
Pfizer, Logo
Roche, Logo
Takeda, Logo
TILLOTTS PHARMA, Logo
ECCO offers sincere gratitude for support of Fellowships and Grants, encouraging young physicians in their careers and promoting innovative scientific research in IBD in Europe:
2025

ECCO Grant, N-ECCO Grant, D-ECCO Grant, IIS Registry Grant (supported by BMS)

2024

ECCO Grant, N-ECCO Grant, D-ECCO Grant, IIS Registry Grant (supported by BMS)

2023

ECCO Grant (supported by BMS)

2021

ECCO Multi-Year Research Grant (supported by Pfizer)

2021

ECCO Research Award (supported by Pfizer)

2019

ECCO-Pfizer Research Grant

2019
ECCO-Pfizer Research Award
2017
ECCO-Vifor Pharma Grant
2016
ECCO-Nestlé Health Science Nutrition Fellowship
2014
ECCO-DigestScience Research Funding
2014
Cosmopharma-funded ECCO Fellowship

Are you interested in supporting an ECCO Fellowship or Grant?